Takayasu Arteritis Clinical Trial in China
Learn more about:
Related Clinical Trial
Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu’s Arteritis
Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
Comparison of Tofacitinib and Methotrexate in Takayasu’s Arteritis
A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)
Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu Arteritis
A Pilot Study in Severe Patients With Takayasu Arteritis.
Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients
Drug-coated Balloon for Takayasu Arteritis Associated Renal Artery Stenosis
The Registry Study of Takayasu Arteritis in East China
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
Use of MRI and PET for Assessing Disease Activity in Takayasu’s Arteritis
Impact and Utility of PET Versus Clinical Score for the Assessment of Inflammatory Activity in Takayasu Arteritis
Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu’s Arteritis
Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis
A Registry Study on Biomarkers of Takayasu’s Arteritis (ARSBTA)
Infliximab Biosimilar in Takayasu’s Arteritis
Exercise in Juvenile Takayasu Disease
Pulmonary Artery Involvement in Takayasu’s Arteritis
Anti-inflammatory Treatment for Inactive Takayasu Arteritis
Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis
Aerobic Capacity and Strength Exercise in Takayasu’s Arteritis
Registration Study of Takayasu’s Arteritis in China
Determining Disease Activity Biomarkers in Individuals With Takayasu’s Arteritis
Takayasu Arteritis Activity Evaluation by Ultrafast Ultrasound Imaging
China Takayasu Arteritis Registry (CTA Registry)
Takayasu Arteritis Clinical Trial in China